Results 321 to 330 of about 8,989,140 (356)

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

Nature Reviews Drug Discovery, 2012
Wolfgang Jarolimek, Arun Sridhar, Steven Whitebread   +2 more
exaly  

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Lancet, The, 2020
Raban V Jeger, Marc-Alexander Ohlow, Norman Mangner   +2 more
exaly  

Predicting drug metabolism: experiment and/or computation?

Nature Reviews Drug Discovery, 2015
Johannes Kirchmair, Andreas H Göller, Bernard Testa   +2 more
exaly  

Drug safety

2018
Jackie Hole, Moira Davies
openaire   +1 more source

Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.

Gastroenterology, 2017
U. Mahadevan, R. McConnell, C. Chambers
semanticscholar   +1 more source

Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem‐containing medications

Pharmacoepidemiology and Drug Safety, 2017
A. Kesselheim, M. Donneyong, G. D. Dal Pan, Esther H Zhou, J. Avorn, S. Schneeweiss, J. Seeger   +6 more
semanticscholar   +1 more source

Drug Safety

BMJ, 1965
openaire   +1 more source

Strategies to optimize expedited investigational new drug safety reports

Nature Reviews Clinical Oncology, 2016
Apostolia Maria Tsimberidou
exaly  

Drug Safety

1982
openaire   +1 more source

Drug Safety

Royal Society of Health Journal, 1980
openaire   +1 more source